You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
海王生物(000078.SZ):2024年度預虧9.5億元-12億元
格隆匯 01-22 17:06

格隆匯1月22日丨海王生物(000078.SZ)公佈2024年年度業績預吿,2024年歸屬於上市公司股東的淨利潤虧損12億元至9.5億元,扣除非經常性損益後的淨利潤虧損12.5億元至10億元,基本每股收益虧損0.4561元/股至0.3611元/股,營業收入280億元至320億元,扣除後營業收入280億元至320億元。

公司主營業務聚焦於醫藥流通領域。近年來,國家醫療衞生體制改革持續深化,醫藥流通企業在經營管理上面臨的壓力與日俱增。報吿期內,隨着集中帶量採購政策與醫保談判降價等措施的持續推進,進一步影響了公司的利潤空間。公司主要醫院客户資金持續緊張,應收賬款回款週期持續拉長,影響了公司的營運資金流轉效率,進而導致公司營業規模的縮減及利潤的下滑。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account